SLC22A23 Inhibitors
SLC22A23 Inhibitors target various aspects of solute transport and cellular metabolism, influencing the functional context of SLC22A23. Given SLC22A23's classification as a solute carrier, modulation of ion and solute transport processes could indirectly impact its activity. Inhibitors of organic anion transporters like Probenecid, as well as compounds like Cimetidine and Quinidine, which are known to interact with drug transporters, could indirectly affect the transport activity of SLC22A23. Diuretics such as Furosemide and Amiloride, which modulate ion transport, might influence processes where SLC22A23 is involved.
Compounds affecting cellular metabolism or ion homeostasis, such as Metformin, Omeprazole, and Chloroquine, could also have implications for SLC22A23's function. Additionally, chemicals like Losartan, Atorvastatin, and 12β-Hydroxydigitoxin, which interact with various transporters or affect ion gradients, might indirectly influence SLC22A23. These compounds, while not directly targeting SLC22A23, are important for exploring the complex processes of solute transport, ion homeostasis, and cellular metabolism.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Probenecid | 57-66-9 | sc-202773 sc-202773A sc-202773B sc-202773C | 1 g 5 g 25 g 100 g | $28.00 $39.00 $100.00 $277.00 | 28 | |
Probenecid is known to inhibit organic anion transporters and could indirectly affect transport pathways involving SLC22A23. | ||||||
Cimetidine | 51481-61-9 | sc-202996 sc-202996A | 5 g 10 g | $62.00 $86.00 | 1 | |
Cimetidine, a known inhibitor of certain drug transporters, may impact solute transport processes relevant to SLC22A23's function. | ||||||
Verapamil | 52-53-9 | sc-507373 | 1 g | $374.00 | ||
Verapamil is a calcium channel blocker that can modulate transport processes and might indirectly affect SLC22A23. | ||||||
Omeprazole | 73590-58-6 | sc-202265 | 50 mg | $67.00 | 4 | |
Omeprazole, a proton pump inhibitor, can influence ion gradients and potentially affect transport mechanisms related to SLC22A23. | ||||||
Furosemide | 54-31-9 | sc-203961 | 50 mg | $41.00 | ||
Furosemide is a loop diuretic that inhibits the Na⁺/K⁺/2Cl⁻ cotransporter and could impact ion and solute transport processes involving SLC22A23. | ||||||
Quinidine | 56-54-2 | sc-212614 | 10 g | $104.00 | 3 | |
Quinidine is known to inhibit various drug transporters and could potentially influence the transport activity of SLC22A23. | ||||||
Losartan | 114798-26-4 | sc-353662 | 100 mg | $130.00 | 18 | |
Losartan, an angiotensin II receptor blocker, may have indirect effects on solute transport, potentially impacting SLC22A23. | ||||||
Metformin | 657-24-9 | sc-507370 | 10 mg | $79.00 | 2 | |
Metformin can influence cellular metabolism and may have indirect effects on solute transport processes involving SLC22A23. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Chloroquine, an antimalarial compound, can affect lysosomal function and autophagy, potentially influencing SLC22A23's role in cellular transport. | ||||||
Atorvastatin | 134523-00-5 | sc-337542A sc-337542 | 50 mg 100 mg | $257.00 $505.00 | 9 | |
Atorvastatin, a statin, is known to interact with drug transporters and could indirectly affect SLC22A23's transport function. | ||||||